Financial reports
10-K
2023 FY
Annual report
11 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
7 Mar 22
Current reports
8-K
LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
13 Dec 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
8-K
Regulation FD Disclosure
10 Aug 23
8-K
Departure of Directors or Certain Officers
31 Jul 23
8-K
Departure of Directors or Certain Officers
14 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jul 23
8-K
LifeMD Appoints William J. Febbo to its Board of Directors
22 Jun 23
8-K
Departure of Directors or Certain Officers
16 Jun 23
8-K
LifeMD, Inc. Announces Closing of New $40 Million Credit Facility
22 Mar 23
8-K
LifeMD Appoints Dr. Joan LaRovere to its Board of Directors
10 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
15 Mar 24
S-8
Registration of securities for employees
21 Dec 23
424B5
Prospectus supplement for primary offering
29 Jun 23
424B5
Prospectus supplement for primary offering
27 Mar 23
424B3
Prospectus supplement
17 Aug 22
424B3
Prospectus supplement
17 Aug 22
POS AM
Prospectus update (post-effective amendment)
1 Jul 22
POS AM
Prospectus update (post-effective amendment)
28 Mar 22
8-A12B
Registration of securities on exchange
4 Oct 21
424B5
Prospectus supplement for primary offering
1 Oct 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
18 May 21
DEF 14A
Definitive proxy
12 May 21
PRE 14A
Preliminary proxy
28 Apr 21
DEF 14A
Definitive proxy
7 Dec 20
PRER14A
Preliminary revised proxy
3 Dec 20
PRER14A
Preliminary revised proxy
25 Nov 20
Other
EFFECT
Notice of effectiveness
8 Jul 22
EFFECT
Notice of effectiveness
3 May 22
CERT
Certification of approval for exchange listing
4 Oct 21
EFFECT
Notice of effectiveness
3 Aug 21
CORRESP
Correspondence with SEC
30 Jul 21
UPLOAD
Letter from SEC
29 Jul 21
EFFECT
Notice of effectiveness
23 Jun 21
CORRESP
Correspondence with SEC
17 Jun 21
UPLOAD
Letter from SEC
15 Jun 21
EFFECT
Notice of effectiveness
25 May 21
Ownership
4
NAVEEN BHATIA
5 Apr 24
4
Eric Harold Yecies
25 Mar 24
4
MARIA E. STAN
25 Mar 24
4
Stefan Galluppi
25 Mar 24
4
Marc David Benathen
25 Mar 24
4
Nicholas P Alvarez
25 Mar 24
4
NAVEEN BHATIA
14 Mar 24
SC 13G/A
Divisadero Street Capital Management, LP
14 Feb 24
4
Justin Schreiber
15 Nov 23
4
Piyush Jindal
8 Nov 23